Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease

Author(s):  McElhiney Linda F

Issue:  Sep/Oct 2013 - Volume 17, Number 5
View All Articles in Issue

Abstract:  Anorectal Crohn’s disease is one of the most problematic and debilitating forms of Crohn’s disease. Crohn’s disease is a type of inflammatory bowel disease that usually affects the intestines but may occur anywhere in the gastrointestinal tract and is frequently refractory to medication, which may ultimately result in proctocolectomy and ileostomy surgeries. It is reported in 3% to 5% of Crohn’s patients and is found in conjunction with colorectal or enteric disease in one-third to one-half of Crohn’s disease patients. This article discusses the use of metronidazole 10% ointment for the treatment of anorectal Crohn’s disease. Since metronidazole is not U.S. Food and Drug Administration approved for treating anorectal Crohn’s disease, and there is no commercially available metronidazole 10% ointment, compounding pharmacists can play a role in providing this dosage form. This article discusses some of the common symptoms of Crohn’s disease and the use of topical metronidazole to treat the disease.

Related Keywords: Linda F. McElhiney, PharmD, RPh, RIACP, FASHP, FACA, metronidazole, formulations, topical preparation, antibiotic, antimicrobial agent, anorectal Crohn's disease, inflammatory bowel disease, anti-inflammatory agents, inflammation, anal fistula plug


Printer-Friendly Version

Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease McElhiney Linda F Sep/Oct 2013 380-383 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310-312 Buy
The Treatment of Canine Atopic Disease Davidson Gigi S May/Jun 2002 210-215 Buy
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K Mar/Apr 2004 101-105 Buy
Basics of Compounding for Raynaud's Disease Glasnapp Andrew Jul/Aug 2003 288-291 Buy
Treating Canine Hepatic Disease Davidson Gigi S May/Jun 2003 188-191 Buy
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions McElhiney Linda F Sep/Oct 2011 376-380 Buy
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Harrington Amy, Williams LaVonn Jul/Aug 2022 293-296 Buy
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Jones Nat, Carvalho Maria, Branvold-Herr Andrea May/Jun 2017 205-211 Buy
Utilization of Compounded Medications in an Oral Medicine Practice Stock Shannon, Rubino Katie, Woo Sook-Bon, Margolis Arthur, Thomas Irena, Aboalela Ali, Treister Nathaniel Mar/Apr 2016 155-158 Buy